Urokinase plasminogen activator in ovarian cancer

European Journal of Gynaecological Oncology

Volumn 17, Issue 2, 1996, Pages 110-113

  Gleeson, N C ^a,c   Hill, B J ^b   Moscinski, L C ^b   Mark, J E ^a   Roberts, W S ^a   Hoffman, M S ^a   Fiorica, J V ^a   Cavanagh, D ^a  

^a Department of Obstetrics   (Ireland)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c Pathology Research Laboratory   (Ireland)

Author keywords

Ovarian cancer; Plasminogen activator; Urokinase

Indexed keywords

UROKINASE;

ARTICLE; BASEMENT MEMBRANE; CANCER INVASION; CYTOSOL; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; METASTASIS; OVARY CANCER; OVARY CARCINOMA;

EPITHELIUM; FEMALE; HUMANS; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; URINARY PLASMINOGEN ACTIVATOR;

EID: 0029970410     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Thorgeirsson U.P., Turpeeniemi-Hujanen T., Neckers L. M. et al.: "Protein synthesis but not DNA synthesis is required for tumour invasion in vitro". Invas. Metast., 1984, 4, 73.
2. Dano K., Andreasen P. A., Grondahl-Hansen J , Kristensen P , Nielsen L. S., Skriver L.: "Plasminogen activators, tissue degradation and cancer". Advances in Cancer Research, 1985, 44, 140.
3. Saksela O.: "Plasminogen activation and regulation of pericellular proteolysis". Biochimica et Biophysica Acta, 1985, 823, 35.
4. Moscatelli D., Rifkin D. B.: "Membrane and matrix localization of proteinases: a common theme in tumor invasion and angiogenesis". Biochimica et Biophysica Acta, 1988, 948, 67.
5. Sugimuru M., Kobayashi H., Kanayama N., Terao T.: "Clinical significance of urokinase-type plasminogen activator (uPA) in invasive cervical cancer of the uterus". Gynecol. Oncol., 1992, 46, 330.
6. Gleeson N., Gonsalves R , Bonnar J.: "Plasminogen activators in endometrial adenocarcinoma" International Journal of Gynaecolgical Cancer, 1991, 1, 223.
7. Saito K., Nagashima M., Iwata M., Hamada H., Sumiyoshi K., Takada Y., Takada A.: "The concentration of tissue plasminogen activator and urokinase in plasma and tissues of patients with ovarian and uterine tumors". Thromb. Res., 1990, 58, 355.
8. Pereyra-Alfonso S., Haedo A., Bal de Kier J. E.: "Correlation between urokinase-type plasminogen activator production and the metastsizing ability of two murine mammary adenocarcinomas". International Journal of Cancer, 1988, 42, 59.
9. Schmitt M., Janicke F., Graeff H.: "Tumour-associated fibrinolysis: the prognostic relevance of plasminogen activators uPA and tPA in human breast cancer". Blood Coagulation and Fibrinolysis , 1990, 1, 695.
10. Carey M. S., Dembo A. J., Simm J. E., Fyles A. W., Treger T., Bush R. S.: "Testing the validity of a prognostic classification in patients with surgically optimal ovarian carcinoma: a 15 year review". Int. Gynecol. Cancer., 1993, 3, 14.
11. Dembo A. J.: "Abdominopelvic radiotherapy in ovarian cancer. A 10-year experience". Cancer, 1985, 55 (9 Suppl.), 2285.
12. Astedt B., Holmberg L.: "Immunological identity of urokinase and ovarian carcinoma plasminogen activator released in tissue culture". Nature, 1976, 261, 595.
13. Camiolo S. M., Siuta M. R., Madeja J. M.: "Improved medium for extraction of plasminogen activator from tissue". Prep. Biochem., 1982, 12, 297.
14. Lowry O. H., Rosebrough N. J., Fair A. L., Randall R. J.: "Protein measurement with the folin phenol reagent". J. Biol. Chem., 1951, 193, 265.
15. Guthrie P., Davey M. L., Phillips P. R.: "A study of 656 patients with early ovarian cancer". Gynecol. Oncol., 1984, 17, 363
16. Omura A. O., Brady M. F., Homesley H. D., Yordan E., Major F. J., Buchsbaum H. J., Park R. C.: "Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: The Gynecologic Oncology Group experience". J. Clin. Oncol., 1991, 9, 1138.
17. Lee L. S., Weinstein I. B.: "Epidermal growth factor, like phorbol esters, induces plasminogen activator in HeLa cells". Nature, 1978, 274, 696.
18. Laiho M., Saksela O., Andreasen P. A., Keski-Oja J.: "Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-β". J. Cell. Biol., 1986, 103, 2403.
19. Hume D. A., Gordon S.: "The correlation between plasminogen activator activity and thymidine incorporation in mouse bone marrow-derived macrophages". Exp . Cell. Res., 1984, 150, 347.
20. Collart M. A., Belin D., Vassalli J. D., De Kossodo S., Vassalli P.: "Gamma Interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, mterleukin-1 and urokinase genes, which are controlled by short-lived repressors". J. Exp. Med., 1986, 164, 2113.
21. Ryan T. J., Seeger J. I., Kumar S.A., Dickerman H. W.: "Estradiol preferentially enhances extracellular tissue plasminogen activator of MCF-7 breast cancer cell". J. Biol. Chem., 1984, 259, 14324.